Skip to main content
Top
Published in: Diabetologia 5/2011

01-05-2011 | Article

The anterior chamber of the eye as a clinical transplantation site for the treatment of diabetes: a study in a baboon model of diabetes

Authors: V. L. Perez, A. Caicedo, D. M. Berman, E. Arrieta, M. H. Abdulreda, R. Rodriguez-Diaz, A. Pileggi, E. Hernandez, S. R. Dubovy, J. M. Parel, C. Ricordi, N. M. Kenyon, N. S. Kenyon, P. O. Berggren

Published in: Diabetologia | Issue 5/2011

Login to get access

Abstract

Aims/hypothesis

The aim of this study was to provide evidence that the anterior chamber of the eye serves as a novel clinical islet implantation site.

Methods

In a preclinical model, allogeneic pancreatic islets were transplanted into the anterior chamber of the eye of a baboon model for diabetes, and metabolic and ophthalmological outcomes were assessed.

Results

Islets readily engrafted on the iris and there was a decrease in exogenous insulin requirements due to insulin secretion from the intraocular grafts. No major adverse effects on eye structure and function could be observed during the transplantation period.

Conclusions/interpretation

Our study demonstrates the long-term survival and function of allogeneic islets after transplantation into the anterior chamber of the eye. The safety and simplicity of this procedure provides support for further studies aimed at translating this technology into the clinic.
Appendix
Available only for authorised users
Literature
1.
go back to reference Shapiro A, Lakey J, Ryan E et al (2000) Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343:230–238PubMedCrossRef Shapiro A, Lakey J, Ryan E et al (2000) Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343:230–238PubMedCrossRef
2.
go back to reference Shapiro A, Ricordi C, Hering B et al (2006) International trial of the Edmonton protocol for islet transplantation. N Engl J Med 355:1318–1330PubMedCrossRef Shapiro A, Ricordi C, Hering B et al (2006) International trial of the Edmonton protocol for islet transplantation. N Engl J Med 355:1318–1330PubMedCrossRef
3.
go back to reference Harlan D, Kenyon N, Korsgren O, Roep B, Society IoD (2009) Current advances and travails in islet transplantation. Diabetes 58:2175–2184PubMedCrossRef Harlan D, Kenyon N, Korsgren O, Roep B, Society IoD (2009) Current advances and travails in islet transplantation. Diabetes 58:2175–2184PubMedCrossRef
4.
go back to reference Korsgren O, Lundgren T, Felldin M et al (2008) Optimising islet engraftment is critical for successful clinical islet transplantation. Diabetologia 51:227–232PubMedCrossRef Korsgren O, Lundgren T, Felldin M et al (2008) Optimising islet engraftment is critical for successful clinical islet transplantation. Diabetologia 51:227–232PubMedCrossRef
5.
go back to reference Pileggi A, Molano R, Ricordi C et al (2006) Reversal of diabetes by pancreatic islet transplantation into a subcutaneous, neovascularized device. Transplantation 81:1318–1324PubMedCrossRef Pileggi A, Molano R, Ricordi C et al (2006) Reversal of diabetes by pancreatic islet transplantation into a subcutaneous, neovascularized device. Transplantation 81:1318–1324PubMedCrossRef
6.
go back to reference Chaffanjon P, Kenyon N, Ricordi C, Kenyon N (2005) Omental anatomy of non-human primates. Surg Radiol Anat 27:287–291PubMedCrossRef Chaffanjon P, Kenyon N, Ricordi C, Kenyon N (2005) Omental anatomy of non-human primates. Surg Radiol Anat 27:287–291PubMedCrossRef
7.
go back to reference Berman D, O’Neil J, Coffey L et al (2009) Long-term survival of nonhuman primate islets implanted in an omental pouch on a biodegradable scaffold. Am J Transplant 9:91–104PubMedCrossRef Berman D, O’Neil J, Coffey L et al (2009) Long-term survival of nonhuman primate islets implanted in an omental pouch on a biodegradable scaffold. Am J Transplant 9:91–104PubMedCrossRef
8.
go back to reference Speier S, Nyqvist D, Köhler M, Caicedo A, Leibiger I, Berggren P (2008) Noninvasive high-resolution in vivo imaging of cell biology in the anterior chamber of the mouse eye. Nat Protoc 3:1278–1286PubMedCrossRef Speier S, Nyqvist D, Köhler M, Caicedo A, Leibiger I, Berggren P (2008) Noninvasive high-resolution in vivo imaging of cell biology in the anterior chamber of the mouse eye. Nat Protoc 3:1278–1286PubMedCrossRef
9.
go back to reference Speier S, Nyqvist D, Cabrera O et al (2008) Noninvasive in vivo imaging of pancreatic islet cell biology. Nat Med 14:574–578PubMedCrossRef Speier S, Nyqvist D, Cabrera O et al (2008) Noninvasive in vivo imaging of pancreatic islet cell biology. Nat Med 14:574–578PubMedCrossRef
10.
go back to reference Berman D, Cabrera O, Kenyon N et al (2007) Interference with tissue factor prolongs intrahepatic islet allograft survival in a nonhuman primate marginal mass model. Transplantation 84:308–315PubMedCrossRef Berman D, Cabrera O, Kenyon N et al (2007) Interference with tissue factor prolongs intrahepatic islet allograft survival in a nonhuman primate marginal mass model. Transplantation 84:308–315PubMedCrossRef
11.
go back to reference Kenyon N, Fernandez L, Lehmann R et al (1999) Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154. Diabetes 48:1473–1481PubMedCrossRef Kenyon N, Fernandez L, Lehmann R et al (1999) Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154. Diabetes 48:1473–1481PubMedCrossRef
12.
go back to reference Kenyon NS, Chatzipetrou M, Masetti M et al (1999) Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154. Proc Natl Acad Sci USA 96:8132–8137PubMedCrossRef Kenyon NS, Chatzipetrou M, Masetti M et al (1999) Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154. Proc Natl Acad Sci USA 96:8132–8137PubMedCrossRef
13.
go back to reference Perez V, Biuckians A, Streilein J (2000) In-vivo impaired T helper 1 cell development in submandibular lymph nodes due to IL-12 deficiency following antigen injection into the anterior chamber of the eye. Ocul Immunol Inflamm 8:9–24PubMed Perez V, Biuckians A, Streilein J (2000) In-vivo impaired T helper 1 cell development in submandibular lymph nodes due to IL-12 deficiency following antigen injection into the anterior chamber of the eye. Ocul Immunol Inflamm 8:9–24PubMed
14.
go back to reference Niederkorn J (2006) See no evil, hear no evil, do no evil: the lessons of immune privilege. Nat Immunol 7:354–359PubMedCrossRef Niederkorn J (2006) See no evil, hear no evil, do no evil: the lessons of immune privilege. Nat Immunol 7:354–359PubMedCrossRef
15.
go back to reference Niederkorn J (2007) The induction of anterior chamber-associated immune deviation. Chem Immunol Allergy 92:27–35PubMedCrossRef Niederkorn J (2007) The induction of anterior chamber-associated immune deviation. Chem Immunol Allergy 92:27–35PubMedCrossRef
Metadata
Title
The anterior chamber of the eye as a clinical transplantation site for the treatment of diabetes: a study in a baboon model of diabetes
Authors
V. L. Perez
A. Caicedo
D. M. Berman
E. Arrieta
M. H. Abdulreda
R. Rodriguez-Diaz
A. Pileggi
E. Hernandez
S. R. Dubovy
J. M. Parel
C. Ricordi
N. M. Kenyon
N. S. Kenyon
P. O. Berggren
Publication date
01-05-2011
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 5/2011
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-011-2091-y

Other articles of this Issue 5/2011

Diabetologia 5/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.